Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

被引:0
作者
Yachida, Junko [1 ,2 ]
Fujihara, Kazuya [1 ]
Yamada, Mayuko Harada [1 ]
Kobayashi, Ayako [1 ,2 ]
Khin, Lay Mon [1 ]
Takizawa, Hiroki [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Kodama, Satoru [1 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
基金
日本学术振兴会;
关键词
cardiovascular disease; coronary artery disease; glucose abnormalities; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; STATIN-TREATED PATIENTS; APOLIPOPROTEIN-A-I; HEART-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; INSULIN-RESISTANCE; TOLERANCE STATUS; LDL CHOLESTEROL; MORTALITY; JAPAN;
D O I
10.1111/dom.15956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 48 条
[1]  
Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010]
[2]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[3]   High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[4]   HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events [J].
Barter, Philip ;
Gotto, Antonio M. ;
LaRosa, John C. ;
Maroni, Jaman ;
Szarek, Michael ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Bittner, Vera ;
Fruchart, Jean-Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) :1301-1310
[5]   Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study [J].
Bartlett, Jacquelaine ;
Predazzi, Irene M. ;
Williams, Scott M. ;
Bush, William S. ;
Kim, Yeunjung ;
Havas, Stephen ;
Toth, Peter P. ;
Fazio, Sergio ;
Miller, Michael .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (03) :206-+
[6]   Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients A Meta-Analysis [J].
Boekholdt, S. Matthijs ;
Arsenault, Benoit J. ;
Hovingh, G. Kees ;
Mora, Samia ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Welch, K. M. A. ;
Amarenco, Pierre ;
DeMicco, David A. ;
Tonkin, Andrew M. ;
Sullivan, David R. ;
Kirby, Adrienne ;
Colhoun, Helen M. ;
Hitman, Graham A. ;
Betteridge, D. John ;
Durrington, Paul N. ;
Clearfield, Michael B. ;
Downs, John R. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Kastelein, John J. P. .
CIRCULATION, 2013, 128 (14) :1504-1512
[7]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[8]   Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel [J].
Boren, Jan ;
Chapman, M. John ;
Krauss, Ronald M. ;
Packard, Chris J. ;
Bentzon, Jacob F. ;
Binder, Christoph J. ;
Daemen, Mat J. ;
Demer, Linda L. ;
Hegele, Robert A. ;
Nicholls, Stephen J. ;
Nordestgaard, Brge G. ;
Watts, Gerald F. ;
Bruckert, Eric ;
Fazio, Sergio ;
Ference, Brian A. ;
Graham, Ian ;
Horton, Jay D. ;
Landmesser, Ulf ;
Laufs, Ulrich ;
Masana, Luis ;
Pasterkamp, Gerard ;
Raal, Frederick J. ;
Ray, Kausik K. ;
Schunkert, Heribert ;
Taskinen, Marja-Riitta ;
van de Sluis, Bart ;
Wiklund, Olov ;
Tokgozoglu, Lale ;
Catapano, Alberico L. ;
Ginsberg, Henry N. .
EUROPEAN HEART JOURNAL, 2020, 41 (24) :2313-+
[9]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[10]   Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes [J].
Carson, April P. ;
Tanner, Rikki M. ;
Yun, Huifeng ;
Glasser, Stephen P. ;
Woolley, J. Michael ;
Thacker, Evan L. ;
Levitan, Emily B. ;
Farkouh, Michael E. ;
Rosenson, Robert S. ;
Brown, Todd M. ;
Howard, George ;
Safford, Monika M. ;
Muntner, Paul .
ANNALS OF EPIDEMIOLOGY, 2014, 24 (08) :581-587